We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info . X close

Respiratory Care Devices Market: Growth, Size, Share, and Trends

Report Code MD 1583
Published in Jun, 2025, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Respiratory Care Devices Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings) - Global Forecast to 2030

Overview

The global respiratory care devices market, valued at US$22.2 billion in 2024, stood at US$23.6 billion in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2025 to 2030, culminating in a forecasted valuation of US$33.6 billion by the end of the period. Various demographic, medical, and environmental factors propel market growth in respiratory care equipment. Among these is the increase in the global prevalence of respiratory conditions. Conditions such as asthma, sleep apnea, and chronic obstructive pulmonary disease (COPD) are typical examples of respiratory problems, mainly caused by smoking, aging populations, and an ever-increasing air pollution level. Awareness toward respiratory support increased with the intense deployment of expenditure on ventilators, oxygen therapies, and monitoring equipment during the COVID-19 period.

Respiratory Care Devices Market

Attractive Opportunities in the Respiratory Care Devices Market

Asia Pacific

Market growth in Asia Pacific can be attributed to the rising air pollution levels, the increasing prevalence of respiratory conditions such as asthma and COPD, and a rapidly expanding geriatric population. Urbanization, lifestyle changes, and higher smoking rates have contributed to a growing burden of chronic respiratory diseases across China, India, and Southeast Asian countries.

The growth of this market can be attributed to significant investments in healthcare infrastructure and technological advancements, which are improving access to respiratory care in urban and rural areas.

The growing middle-class population and increasing demand for affordable and home-based healthcare solutions are fueling the adoption of portable oxygen therapy devices and remote monitoring tools.

Asia Pacific is expected to register the highest CAGR of 8.0% in the respiratory care devices market.

Large patient pool and expanding medical device manufacturing capabilities make Asia Pacific a highly attractive market for global and local respiratory care device manufacturers.

Global Respiratory Care Devices Market Dynamics

DRIVER: Increasing prevalence of respiratory diseases

The increasing incidence of respiratory diseases is one of the prime factors contributing to the market growth in respiratory-care devices. Conditions such as chronic obstructive pulmonary disease, asthma, sleep apnea, and acute respiratory distress syndrome have proliferated in the worldwide profiles of populations due to aging population profiles, rising tobacco consumption, increasing exposure to indoor and outdoor air pollution, and growing incidences of respiratory infections. Since these diseases need respiratory support and monitoring and may require long-term or lifelong support, the demand continues to grow for respiratory-care devices such as ventilators, oxygen concentrators, nebulizers, as well as CPAP/BiPAP machines, which in turn give a considerable boost to the market.

RESTRAINT: Unfavorable reimbursement scenario

Poor reimbursement policies regarding respiratory care diagnostics will continue to act as a major force hindering the development of the market for respiratory care devices. In several regions of the world, especially developing and underdeveloped countries, reimbursement for various diagnostic procedures for respiratory problems, namely spirometry, sleep studies, and imaging tests, is scant or may be absent from the coverage of either public or private insurance companies. Therefore, timely and accurate diagnosis becomes difficult for healthcare facilities and patients due to the high price tags attached to it. Even in developed markets like the US, reimbursement policies can be complex, restrictive, and subject to frequent changes, especially under Medicare and Medicaid programs. This often results in out-of-pocket costs for patients, reducing access to timely and adequate treatment. Furthermore, reimbursement approval processes for new or technologically advanced devices can be slow and inconsistent, discouraging innovation and limiting the adoption of improved solutions. The lack of standardized global reimbursement frameworks also creates market fragmentation, making it difficult for manufacturers to scale across regions and optimize pricing strategies.

 

OPPORTUNITY: Growing demand for home care therapeutic devices

The growing need for home care therapeutic devices is a key area in the respiratory care device market. This trend is led by several reasons, including increasing cases of chronic respiratory diseases such as COPD, asthma, and sleep apnea that require long-term treatment. Home care is becoming more and more popular with patients and healthcare systems due to its cost-effectiveness, convenience, enhanced patient comfort, and compliance. As a result of technological advances, the products got smaller, more user-friendly, and more energy-efficient, rendering them ready for household use: the entry of portable oxygen concentrators, CPAP/BiPAP devices, and nebulizers. Another surge in the uptake of home respiratory therapies was driven by the heightened awareness generated by COVID-19 regarding the availability of remote respiratory treatment and the minimization of hospitalization. Moreover, factors such as the global aging population and higher healthcare expenditures are fueling this demand, so the segment is a highly contemplated growth area for manufacturers and service providers to pursue.

CHALLENGES: Low awareness and lack of diagnosis of respiratory diseases

Low levels of awareness and diagnosis for respiratory diseases are a significant setback for the growth of the respiratory care devices market. Healthcare facilities are still inaccessible in most low- and middle-income countries, while public awareness about respiratory diseases such as COPD, asthma, and sleep apnea is relatively low. Therefore, many individuals remain undiagnosed or diagnosed late in the disease stages when effective intervention becomes complex. In addition, presentations of chronic respiratory conditions are often misconstrued or overlooked, and this brings about delays in care. Poor care infrastructure in regard to spirometry and sleep labs, especially in rural and under-served communities, contributes to the difficulty of early detection. Underdiagnosis is also driven by cultural stigmatization of the use of breathing aids and an overall lack of knowledge related to the importance of respiratory health.

Global Respiratory Care Devices Market Ecosystem Analysis

The ecosystem of the respiratory care devices market includes manufacturers, distributors, research & product developers, regulatory bodies, and end users. Manufacturers include the organizations involved in the entire process of research, product development, optimization, and launch. Distributors include third parties and eCommerce sites, which are linked with organizations for marketing.

Respiratory Care Devices Market
 

By product type, the therapeutic devices segment holds the highest share in the respiratory care devices market during the forecast period.

Based on product type, therapeutic devices hold the largest market share in the respiratory care devices market due to their critical role in the management and treatment of various acute and chronic respiratory illnesses. For patients with respiratory failure, sleep apnea, asthma, and COPD in particular, these devices are essential for providing life-sustaining respiratory support. These include high-flow nasal cannula systems, CPAP and BiPAP machines, ventilators, nebulizers, and oxygen concentrators. The demand for therapeutic equipment has increased dramatically due to the need for long-term home-based respiratory therapy, the global prevalence of chronic illnesses, and a rise in hospitalizations. The demand for ventilators and oxygen therapy surged during the COVID-19 pandemic, reinforcing their status as essential home care and critical care tools.

By disease indication, the COPD segment holds the highest share in the respiratory care devices market during the forecast period.

Based on disease indication, the market for respiratory care devices is dominated by Chronic Obstructive Pulmonary Disease (COPD), which is becoming more of a global phenomenon, especially among the elderly. This is because higher demand is placed on needed equipment, such as non-invasive ventilators, oxygen concentrators, nebulizers, and monitoring devices. Due to being a progressive and irreversible condition, COPD requires constant care and long-term respiratory therapy. The condition is also aggravated by high-risk factors that are prevalent in developing and developed countries, such as smoking, air pollution, and occupational hazards. Furthermore, since COPD is typically hospitalized and gets exacerbations, constant use of respiratory equipment at home and in healthcare facilities is necessary.

North America is expected to account for the largest market share of the global respiratory care devices market during the forecast period.

Driven by several important elements particular to North America, the market for respiratory care products is growing. Significant causes of the high rates of chronic respiratory diseases, including asthma, sleep apnea, and COPD, are the aging population, long histories of smoking, and rising obesity rates. Early diagnosis and treatment of these diseases are made possible by the strong healthcare system of the area and a rising understanding of the need for respiratory health.

LARGEST SHARE IN 2024
US: FASTEST-GROWING MARKET IN REGION
Respiratory Care Devices Market

Recent Developments of Respiratory Care Devices Market

  • In May 2025, ResMed acquired VirtuOx, a leading independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions.
  • In March 2025, Fisher & Paykel Healthcare launched the F&P Nova Nasal mask in New Zealand and Australia.
  • In March 2025, Drager unveiled NIOSH-certified ProAir, an advanced closed-circuit breathing apparatus (CCBA) designed to provide a continuous oxygen supply for up to four hours.
  • In November 2024, Fisher & Paykel Healthcare launched F&P Nova Micro, the smallest and lightest mask yet in the US.

Key Market Players

Want to explore hidden markets that can drive new revenue in Respiratory Care Devices Market?

Scope of the Report

Report Metric Details
Market size available for years 2025-2030
Base Year Considered 2024
Forecast period 2025-2030
Forecast units Value (USD Million/Billion)
Segments covered Product Type, Disease Indication, End User, and Region
Geographies covered North America (US & Canada), Europe (Germany, UK, France, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, Australia, South Korea, India, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and Rest of Latin America), Middle East & Africa (GCC countries and Rest of Middle East & Africa)

Frequently Asked Questions (FAQ)

What are the drivers of the respiratory care devices market?

Rising prevalence of chronic respiratory diseases such as COPD and asthma, increasing geriatric population, rising levels of air pollution, and growing demand for home-based care.

Which product type dominates the respiratory care devices market?

The therapeutic devices segment dominates the respiratory care devices market.

Who are the end users of the respiratory care devices market? Which end user is leading?

End users include hospitals, home care settings, ambulatory care centers, and others. Hospitals held the largest market share in 2024.

Who are the key players in the respiratory care devices market?

Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), ResMed Inc. (US), Fisher & Paykel Healthcare Limited (New Zealand), Drägerwerk AG & Co. KGaA (Germany), and GE Healthcare (US).

Which region is lucrative for the respiratory care devices market?

North America is expected to witness the highest growth during the forecast period.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Respiratory Care Devices Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
37
RESEARCH METHODOLOGY
43
EXECUTIVE SUMMARY
59
PREMIUM INSIGHTS
63
MARKET OVERVIEW
67
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Rising prevalence of respiratory diseases
    - Surging incidence rate of preterm births
    - Growing outbreaks of infectious diseases affecting respiratory systems
    - Rising population with sleep disorders
    - Improved patient outcomes using respiratory care devices
    - Rising R&D investments for technological advancement of medical devices
    RESTRAINTS
    - Unfavorable reimbursement scenario for respiratory care diagnostics
    - Availability of low-cost products from local manufacturers
    - High cost of CPAP machines
    OPPORTUNITIES
    - Growing demand for home care therapeutic devices
    - Market growth opportunities in Asia Pacific
    - Increasing preference for self-testing
    - Growing awareness about ill effects of untreated sleep apnea
    CHALLENGES
    - Low awareness and lack of diagnosis of respiratory diseases
    - Harmful effects of certain respiratory care devices on neonates
    - Lack of patient compliance with CPAP therapy
  • 5.3 REGULATORY LANDSCAPE
  • 5.4 REGULATORY FRAMEWORK
    NORTH AMERICA
    - US
    - Canada
    EUROPE
    ASIA PACIFIC
    - Japan
    - China
    - India
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.5 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - OXYGEN THERAPY SYSTEMS
    - AIRWAY MANAGEMENT DEVICES
    - PULMONARY FUNCTION TESTING (PFT) DEVICES
    - MONITORING SENSORS
    COMPLEMENTARY TECHNOLOGIES
    - TELEMEDICINE PLATFORMS
    - MOBILE HEALTH (MHEALTH) APPS
    - WEARABLE RESPIRATORY TRACKERS
    ADJACENT TECHNOLOGIES
    - SMART INHALERS
    - ENVIRONMENTAL SENSING DEVICES
  • 5.6 INDUSTRY TRENDS
    MINIATURIZATION AND PORTABILITY
    SMART CONNECTIVITY AND IOT (INTERNET OF THINGS) INTEGRATION
    GROWING DEMAND FOR MULTIMODAL VENTILATION
    RISING ADOPTION OF NON-INVASIVE VENTILATION
    PERSONALIZED TREATMENT SOLUTIONS
  • 5.7 VALUE CHAIN ANALYSIS
  • 5.8 SUPPLY CHAIN ANALYSIS
  • 5.9 TRADE ANALYSIS
    TRADE ANALYSIS FOR RESPIRATORY CARE DEVICES PRODUCTS
  • 5.10 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES, BY KEY PLAYER, 2024 (USD)
    AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES, BY REGION, 2024 (USD)
  • 5.11 REIMBURSEMENT SCENARIO
  • 5.12 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.13 ADJACENT MARKET ANALYSIS
  • 5.14 PATENT ANALYSIS
  • 5.15 ECOSYSTEM COVERAGE
  • 5.16 KEY CONFERENCES AND EVENTS (2025-2026)
  • 5.17 KEY CONFERENCES & EVENTS DURING 2025-2026
  • 5.18 CASE STUDIES
  • 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
  • 5.20 KEY STAKEHOLDERS & BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.21 KEY BUYING CRITERIA
  • 5.22 INVESTMENT/VENTURE CAPITAL
  • 5.23 UNMET NEEDS/END-USER EXPECTATIONS IN RESPIRATORY CARE DEVICES MARKET
  • 5.24 IMPACT OF ARTIFICIAL INTELLIGENCE (AI) ON RESPIRATORY CARE DEVICES MARKET
  • 5.25 IMPACT OF 2025 US TARIFF – OVERVIEW
    INTRODUCTION
  • 5.26 KEY TARIFF RATES
  • 5.27 PRICE IMPACT ANALYSIS
    IMPACT ON COUNTRY/REGION
    - US
    - Europe
    - Asia Pacific
  • 5.28 IMPACT ON END-USER INDUSTRIES
RESPIRATORY CARE DEVICES MARKET, BY PRODUCT
113
  • 6.1 INTRODUCTION
  • 6.2 THERAPEUTIC RESPIRATORY CARE DEVICES
    PAP DEVICES
    - CPAP devices
    - APAP devices
    - BiPAP devices
    VENTILATORS
    - ICU ventilators
    - Portable/Transportable ventilators
    NEBULIZERS
    - Jet nebulizers
    - Mesh nebulizers
    - Ultrasonic nebulizers
    HUMIDIFIERS
    - Heated humidifiers
    - Passover humidifiers
    OXYGEN CONCENTRATORS
    - Fixed oxygen concentrators
    - Portable oxygen concentrators
    INHALERS
    - Metered-dose inhalers (MDIs)
    - Dry powder inhalers (DPIs)
    REUSABLE RESUSCITATORS
    - Disposable and reusable nature to drive demand
    NITRIC OXIDE DELIVERY UNITS
    - Rising emphasis of companies on developing innovative and advanced nitric oxide delivery units to drive market
    OXYGEN HOODS
    - Growing prevalence of respiratory diseases in kids to drive market growth
  • 6.3 MONITORING DEVICES
    PULSE OXIMETERS
    - Pulse oximeter sensors
    - Pulse oximeter equipment
    CAPNOGRAPHS
    - Ongoing R&D on capnographs to offer lucrative growth opportunities
    GAS ANALYZERS
    - Increasing demand for point-of-care testing to drive demand
  • 6.4 DIAGNOSTIC RESPIRATORY CARE DEVICES
    SPIROMETERS
    - Rising technological advancements in spirometers to support market growth
    POLYSOMNOGRAPHY DEVICES (PSG DEVICES)
    - Rising incidence of obstructive sleep apnea to drive demand
    PEAK FLOW METERS
    - Low-cost and uncomplicated nature to drive segmental growth
    OTHER DIAGNOSTIC DEVICES
  • 6.5 CONSUMABLES & ACCESSORIES
    MASKS
    - Reusable masks
    - Disposable masks
    DISPOSABLE RESUSCITATORS
    - Growing focus on reducing cross-contamination cases in patients to foster segmental growth
    TRACHEOSTOMY TUBES
    - Introduction of advanced products with ergonomic designs to drive market growth
    BREATHING CIRCUITS
    - Healthcare professionals’ efforts to improve infection control practices to drive demand
    NASAL CANNULAE
    - Increasing focus on minimally invasive surgery techniques to fuel demand
    OTHER CONSUMABLES & ACCESSORIES
RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION
192
  • 7.1 INTRODUCTION
  • 7.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
    RISING INDOOR AND OUTDOOR AIR POLLUTION LEVELS TO DRIVE MARKET
  • 7.3 SLEEP APNEA
    GROWING INCIDENCE OF OBESITY AND CARDIOVASCULAR DISEASES TO FAVOR MARKET GROWTH
  • 7.4 ASTHMA
    INCREASING AIR POLLUTION AND GROWING USE OF TOBACCO-BASED PRODUCTS TO DRIVE MARKET
  • 7.5 INFECTIOUS DISEASES
    GROWING NUMBER OF TB PATIENTS TO BOOST MARKET GROWTH
  • 7.6 OTHER DISEASE INDICATIONS
RESPIRATORY CARE DEVICES MARKET, BY END USER
204
  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    GROWING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO DRIVE MARKET
  • 8.3 HOME CARE SETTINGS
    INCREASING ACCEPTANCE OF HOME CARE DEVICES BY PATIENTS TO BOOST GROWTH
  • 8.4 AMBULATORY CARE CENTERS (ACCS)
    IMPROVED PATIENT EXPERIENCE IN AMBULATORY CARE CENTERS TO DRIVE MARKET
  • 8.5 OTHER END USERS
RESPIRATORY CARE DEVICES MARKET, BY REGION
213
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    US
    - Rapid growth in geriatric population to boost market
    CANADA
    - Large pool of undiagnosed patients and vaping trends drive market
  • 9.3 EUROPE
    MACROECONOMIC OUTLOOK FOR EUROPE
    GERMANY
    - Increasing public healthcare expenditure to foster market growth
    FRANCE
    - High prevalence of COPD to surge demand
    UK
    - Growing demand for minimally invasive surgeries to drive market
    ITALY
    - Growing involvement of private sector in healthcare market to drive market
    SPAIN
    - Need to improve healthcare infrastructure due to aging demographic to drive demand
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    JAPAN
    - Availability of universal healthcare reimbursement policy to drive market
    CHINA
    - Initiatives to modernize healthcare system and reimbursement facilities to support market growth
    INDIA
    - Increasing focus of global players on domestic market to drive market
    AUSTRALIA
    - High prevalence of chronic lung diseases to drive demand
    SOUTH KOREA
    - Expanding geriatric population to fuel market
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    BRAZIL
    - Government initiatives to improve healthcare sector to drive market
    MEXICO
    - Rising obesity rate to increase incidence of respiratory diseases
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    MACROECONOMIC OUTLOOK FOR MEA
    GCC COUNTRIES
    - INCREASING INCIDENCE OF RESPIRATORY DISEASES IN GCC DRIVES MARKET
    REST OF MIDDLE EAST & AFRICA
COMPETITIVE LANDSCAPE
374
  • 10.1 OVERVIEW
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN RESPIRATORY CARE DEVICES MARKET
  • 10.3 REVENUE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company footprint
    - Region footprint
    - Product type footprint
    - Disease indication footprint
    - End user footprint
  • 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    RESPONSIVE COMPANIES
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
  • 10.7 VALUATION & FINANCIAL METRICS
    FINANCIAL METRICS
    COMPANY VALUATION
  • 10.8 BRAND/PRODUCT COMPARISON
  • 10.9 COMPETITIVE SCENARIO
    PRODUCT & SERVICE LAUNCHES AND APPROVALS
    DEALS
    EXPANSIONS
    OTHER DEVELOPMENTS
COMPANY PROFILES
396
  • 11.1 KEY PLAYERS
    KONINKLIJKE PHILIPS N.V.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MEDTRONIC
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    RESMED INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    FISHER & PAYKEL HEALTHCARE LIMITED
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    DRÄGERWERK AG & CO. KGAA
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MASIMO
    - Business overview
    - Products offered
    - Recent developments
    GETINGE
    - Business overview
    - Products offered
    - Recent developments
    NIHON KOHDEN CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    GE HEALTHCARE
    - Business overview
    - Products offered
    - Recent developments
    HILLROM & WELCH ALLYN (BAXTER INTERNATIONAL, INC)
    - Business overview
    - Products offered
    - Recent developments
    ADAPTHEALTH, LLC
    - Business overview
    - Products offered
    TELEFLEX INCORPORATED
    - Business overview
    - Products offered
    AIR LIQUIDE
    - Business overview
    - Products offered
    - Recent developments
    ICU MEDICAL, INC.
    - Business overview
    - Products offered
    - Recent developments
    HAMILTON MEDICAL
    - Business overview
    - Products offered
    - Recent developments
  • 11.2 OTHER PLAYERS
    MEDLINE INDUSTRIES, LP
    ALLIED MEDICAL LLC
    NONIN
    APEX MEDICAL
    ROTECH HEALTHCARE, INC.
    LÖWENSTEIN MEDICAL SE & CO. KG
    WEINMANN EMERGENCY MEDICAL TECHNOLOGY GMBH + CO. KG
    DRIVE DEVILBISS HEALTHCARE
    OMRON HEALTHCARE, INC.
    HUM GMBH
APPENDIX
466
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 ANNUAL AVERAGE EXCHANGE RATE FOR CURRENCY CONVERSION, 2020–2024
  • TABLE 2 RESEARCH ASSUMPTIONS
  • TABLE 3 RISK ASSESSMENT: RESPIRATORY CARE DEVICES MARKET
  • TABLE 4 REGION-WISE DATA ON LIFESTYLE DISEASES
  • TABLE 5 TOP 10 COUNTRIES WITH HIGHEST RATES OF PRETERM BIRTH PER 100 LIVE BIRTHS
  • TABLE 6 PRODUCT LAUNCHES
  • TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT UNTREATED SLEEP APNEA
  • TABLE 8 US: CLASSIFICATION OF MEDICAL EQUIPMENT
  • TABLE 9 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 11 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 13 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 IMPORT DATA FOR RESPIRATORY CARE DEVICES (HS CODE 901920), BY COUNTRY, 2020–2024 (USD THOUSAND)
  • TABLE 18 EXPORT DATA FOR RESPIRATORY CARE DEVICES (HS CODE 901920), BY COUNTRY, 2020–2024 (USD THOUSAND)
  • TABLE 19 RESPIRATORY CARE DEVICES MARKET: REIMBURSEMENT SCENARIO
  • TABLE 20 RESPIRATORY CARE DEVICES MARKET: PORTERS FIVE FORCE ANALYSIS
  • TABLE 21 RESPIRATORY CARE DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
  • TABLE 22 CASE STUDY 1: LONG-TERM VENTILATION WITH VARIABLE PSV
  • TABLE 23 CASE STUDY 2: OPTIMAL UTILIZATION OF MECHANICAL VENTILATOR AT TERTIARY CARE HOSPITAL DURING COVID-19 PANDEMIC
  • TABLE 24 CASE STUDY 3: CHANGING PATTERNS IN LONG-TERM NON-INVASIVE VENTILATION
  • TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY CARE DEVICES
  • TABLE 26 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES
  • TABLE 27 RESPIRATORY CARE DEVICES MARKET: UNMET NEEDS
  • TABLE 28 RESPIRATORY CARE DEVICES MARKET: APPLICATION OF ARTIFICIAL INTELLIGENCE
  • TABLE 29 US-ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 30 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR RESPIRATORY CARE DEVICES
  • TABLE 31 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 32 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 33 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 34 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 35 PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 36 PAP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 37 PAP DEVICES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
  • TABLE 38 MAJOR PLAYERS OFFERING CPAP DEVICES
  • TABLE 39 CPAP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 40 MAJOR PLAYERS OFFERING APAP DEVICES
  • TABLE 41 APAP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 42 MAJOR PLAYERS OFFERING BIPAP DEVICES
  • TABLE 43 BIPAP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 44 VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 45 VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 46 VENTILATORS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
  • TABLE 47 MAJOR PLAYERS OFFERING ICU VENTILATORS
  • TABLE 48 ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 49 ICU VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 50 HIGH-END VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 51 MID-END VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 52 BASIC VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 53 MAJOR PLAYERS OFFERING PORTABLE/TRANSPORTABLE VENTILATORS
  • TABLE 54 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 55 MAJOR PLAYERS OFFERING NEBULIZERS
  • TABLE 56 NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 57 NEBULIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 58 NEBULIZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
  • TABLE 59 JET NEBULIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 60 MESH NEBULIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 61 ULTRASONIC NEBULIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 62 HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 63 HUMIDIFIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 64 MAJOR PLAYERS OFFERING HEATED HUMIDIFIERS
  • TABLE 65 HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 66 MAJOR PLAYERS OFFERING PASSOVER HUMIDIFIERS
  • TABLE 67 PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 68 MAJOR PLAYERS OFFERING OXYGEN CONCENTRATORS
  • TABLE 69 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 70 OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 71 FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 72 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 73 INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 74 INHALERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 75 METERED-DOSE INHALERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 76 DRY POWDER INHALERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 77 MAJOR PLAYERS OFFERING REUSABLE RESUSCITATORS
  • TABLE 78 REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 79 MAJOR PLAYERS OFFERING NITRIC OXIDE DELIVERY UNITS
  • TABLE 80 NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 81 MAJOR PLAYERS OFFERING OXYGEN HOODS
  • TABLE 82 OXYGEN HOODS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 83 RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 84 RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 85 MAJOR PLAYERS OFFERING PULSE OXIMETERS
  • TABLE 86 PULSE OXIMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 87 PULSE OXIMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 88 PULSE OXIMETER SENSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 89 MAJOR PLAYERS OFFERING PULSE OXIMETER EQUIPMENT
  • TABLE 90 PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 91 MAJOR PLAYERS OFFERING CAPNOGRAPHS
  • TABLE 92 CAPNOGRAPHS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 93 MAJOR PLAYERS OFFERING GAS ANALYZERS
  • TABLE 94 GAS ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 95 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 96 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 97 MAJOR PLAYERS OFFERING SPIROMETERS
  • TABLE 98 SPIROMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 99 SPIROMETERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS)
  • TABLE 100 MAJOR PLAYERS OFFERING POLYSOMNOGRAPHY DEVICES
  • TABLE 101 POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 102 MAJOR PLAYERS OFFERING PEAK FLOW METERS
  • TABLE 103 PEAK FLOW METERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 104 OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 105 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 106 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 107 MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 108 MASKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 109 REUSABLE MASKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 110 DISPOSABLE MASKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 111 DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 112 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 113 BREATHING CIRCUITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 114 NASAL CANNULAE MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 115 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 116 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 117 DISEASE INDICATION: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 118 RESPIRATORY CARE DEVICES MARKET FOR COPD, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 119 COUNTRY-WISE DATA ON SLEEP APNEA PATIENTS
  • TABLE 120 RESPIRATORY CARE DEVICES MARKET FOR SLEEP APNEA, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 121 RESPIRATORY CARE DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 122 INCIDENCE OF TB (RATE PER 100,000 POPULATION)
  • TABLE 123 RESPIRATORY CARE DEVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 124 RESPIRATORY CARE DEVICES MARKET FOR OTHER DISEASE INDICATIONS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 125 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 126 END USER: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 127 RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 128 RESPIRATORY CARE DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 129 RESPIRATORY CARE DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 130 RESPIRATORY CARE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 131 RESPIRATORY CARE DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
  • TABLE 132 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 133 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 134 NORTH AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 135 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 136 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 137 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 138 NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 139 NORTH AMERICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 140 NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 141 NORTH AMERICA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 142 NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 143 NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 144 NORTH AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 145 NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 146 NORTH AMERICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 147 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 148 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 149 US: KEY MACROINDICATORS
  • TABLE 150 US: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 151 US: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 152 US: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 153 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 154 US: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 155 US: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 156 US: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 157 US: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 158 US: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 159 US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 160 US: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 161 US: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 162 US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 163 US: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 164 US: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 165 US: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 166 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020)
  • TABLE 167 CANADA: KEY MACROINDICATORS
  • TABLE 168 CANADA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 169 CANADA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 170 CANADA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 171 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 172 CANADA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 173 CANADA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 174 CANADA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 175 CANADA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 176 CANADA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 177 CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 178 CANADA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 179 CANADA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 180 CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 181 CANADA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 182 CANADA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 183 CANADA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 184 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 185 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 186 EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 187 EUROPE: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 188 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 189 EUROPE: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 190 EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 191 EUROPE: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 192 EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 193 EUROPE: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 194 EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 195 EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 196 EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 197 EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 198 EUROPE: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 199 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 200 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 201 GERMANY: KEY MACROINDICATORS
  • TABLE 202 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 203 GERMANY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 204 GERMANY: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 205 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 206 GERMANY: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 207 GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 208 GERMANY: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 209 GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 210 GERMANY: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 211 GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 212 GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 213 GERMANY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 214 GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 215 GERMANY: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 216 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 217 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 218 FRANCE: KEY MACROINDICATORS
  • TABLE 219 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 220 FRANCE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 221 FRANCE: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 222 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 223 FRANCE: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 224 FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 225 FRANCE: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 226 FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 227 FRANCE: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 228 FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 229 FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 230 FRANCE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 231 FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 232 FRANCE: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 233 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 234 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 235 UK: KEY MACROINDICATORS
  • TABLE 236 UK: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 237 UK: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 238 UK: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 239 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 240 UK: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 241 UK: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 242 UK: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 243 UK: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 244 UK: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 245 UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 246 UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 247 UK: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 248 UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 249 UK: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 250 UK: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 251 UK: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 252 ITALY: KEY MACROINDICATORS
  • TABLE 253 ITALY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 254 ITALY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 255 ITALY: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 256 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 257 ITALY: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 258 ITALY: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 259 ITALY: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 260 ITALY: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 261 ITALY: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 262 ITALY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 263 ITALY: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 264 ITALY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 265 ITALY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 266 ITALY: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 267 ITALY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 268 ITALY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 269 SPAIN: KEY MACROINDICATORS
  • TABLE 270 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 271 SPAIN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 272 SPAIN: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 273 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 274 SPAIN: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 275 SPAIN: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 276 SPAIN: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 277 SPAIN: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 278 SPAIN: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 279 SPAIN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 280 SPAIN: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 281 SPAIN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 282 SPAIN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 283 SPAIN: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 284 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 285 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 286 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 287 REST OF EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 288 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 289 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 290 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 291 REST OF EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 292 REST OF EUROPE: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 293 REST OF EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 294 REST OF EUROPE: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 295 REST OF EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 296 REST OF EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 297 REST OF EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 298 REST OF EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 299 REST OF EUROPE: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 300 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 301 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 302 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 303 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 304 ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 305 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 306 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 307 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 308 ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 309 ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 310 ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 311 ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 312 ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 313 ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 314 ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 315 ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 316 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 317 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 318 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 319 JAPAN: KEY MACROINDICATORS
  • TABLE 320 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 321 JAPAN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 322 JAPAN: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 323 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 324 JAPAN: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 325 JAPAN: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 326 JAPAN: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 327 JAPAN: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 328 JAPAN: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 329 JAPAN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 330 JAPAN: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 331 JAPAN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 332 JAPAN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 333 JAPAN: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 334 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 335 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 336 CHINA: KEY MACROINDICATORS
  • TABLE 337 CHINA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 338 CHINA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 339 CHINA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 340 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 341 CHINA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 342 CHINA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 343 CHINA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 344 CHINA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 345 CHINA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 346 CHINA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 347 CHINA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 348 CHINA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 349 CHINA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 350 CHINA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 351 CHINA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 352 CHINA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 353 INDIA: KEY MACROINDICATORS
  • TABLE 354 INDIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 355 INDIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 356 INDIA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 357 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 358 INDIA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 359 INDIA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 360 INDIA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 361 INDIA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 362 INDIA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 363 INDIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 364 INDIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 365 INDIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 366 INDIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 367 INDIA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 368 INDIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 369 INDIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 370 AUSTRALIA: KEY MACROINDICATORS
  • TABLE 371 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 372 AUSTRALIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 373 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 374 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 375 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 376 AUSTRALIA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 377 AUSTRALIA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 378 AUSTRALIA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 379 AUSTRALIA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 380 AUSTRALIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 381 AUSTRALIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 382 AUSTRALIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 383 AUSTRALIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 384 AUSTRALIA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 385 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 386 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 387 SOUTH KOREA: KEY MACROINDICATORS
  • TABLE 388 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 389 SOUTH KOREA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 390 SOUTH KOREA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 391 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 392 SOUTH KOREA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 393 SOUTH KOREA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 394 SOUTH KOREA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 395 SOUTH KOREA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 396 SOUTH KOREA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 397 SOUTH KOREA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 398 SOUTH KOREA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 399 SOUTH KOREA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 400 SOUTH KOREA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 401 SOUTH KOREA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 402 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 403 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 404 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 405 REST OF ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 406 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 407 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 408 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 409 REST OF ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 410 REST OF ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 411 REST OF ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 412 REST OF ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 413 REST OF ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 414 REST OF ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 415 REST OF ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 416 REST OF ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 417 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 418 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 419 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 420 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 421 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 422 LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 423 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 424 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 425 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 426 LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 427 LATIN AMERICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 428 LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 429 LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 430 LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 431 LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 432 LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 433 LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 434 LATIN AMERICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 435 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 436 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 437 BRAZIL: KEY MACROINDICATORS
  • TABLE 438 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 439 BRAZIL: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 440 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 441 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 442 BRAZIL: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 443 BRAZIL: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 444 BRAZIL: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 445 BRAZIL: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 446 BRAZIL: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 447 BRAZIL: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 448 BRAZIL: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 449 BRAZIL: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 450 BRAZIL: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 451 BRAZIL: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 452 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 453 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 454 MEXICO: KEY MACROINDICATORS
  • TABLE 455 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 456 MEXICO: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 457 MEXICO: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 458 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 459 MEXICO: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 460 MEXICO: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 461 MEXICO: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 462 MEXICO: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 463 MEXICO: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 464 MEXICO: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 465 MEXICO: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 466 MEXICO: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 467 MEXICO: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 468 MEXICO: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 469 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 470 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 471 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 472 REST OF LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 473 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 474 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 475 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 476 REST OF LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 477 REST OF LATIN AMERICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 478 REST OF LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 479 REST OF LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 480 REST OF LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 481 REST OF LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 482 REST OF LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 483 REST OF LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 484 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 485 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 486 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 487 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
  • TABLE 488 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 489 MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 490 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 491 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 492 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 493 MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 494 MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 495 MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 496 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 497 MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 498 MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 499 MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 500 MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 501 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 502 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 503 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 504 GCC COUNTRIES: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 505 GCC COUNTRIES: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 506 GCC COUNTRIES: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 507 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 508 GCC COUNTRIES: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 509 GCC COUNTRIES: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 510 GCC COUNTRIES: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 511 GCC COUNTRIES: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 512 GCC COUNTRIES: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 513 GCC COUNTRIES: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 514 GCC COUNTRIES: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 515 GCC COUNTRIES: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 516 GCC COUNTRIES: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 517 GCC COUNTRIES: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 518 GCC COUNTRIES: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 519 GCC COUNTRIES: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 520 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 521 REST OF MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 522 REST OF MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 523 REST OF MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 524 REST OF MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 525 REST OF MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 526 REST OF MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 527 REST OF MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 528 REST OF MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 529 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 530 REST OF MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION)
  • TABLE 531 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 532 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 533 REST OF MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION)
  • TABLE 534 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION)
  • TABLE 535 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION)
  • TABLE 536 STRATEGIES ADOPTED BY KEY PLAYERS IN RESPIRATORY CARE DEVICES MARKET, JANUARY 2021–APRIL 2025
  • TABLE 537 RESPIRATORY CARE DEVICES MARKET: DEGREE OF COMPETITION
  • TABLE 538 RESPIRATORY CARE DEVICES MARKET: REGION FOOTPRINT
  • TABLE 539 RESPIRATORY CARE DEVICES MARKET: PRODUCT TYPE FOOTPRINT
  • TABLE 540 RESPIRATORY CARE DEVICES MARKET: DISEASE INDICATION FOOTPRINT
  • TABLE 541 RESPIRATORY CARE DEVICES MARKET: END USER FOOTPRINT
  • TABLE 542 RESPIRATORY CARE DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 543 RESPIRATORY CARE DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 544 RESPIRATORY CARE DEVICES MARKET: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–APRIL 2025
  • TABLE 545 RESPIRATORY CARE DEVICES MARKET: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 546 RESPIRATORY CARE DEVICES MARKET: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 547 RESPIRATORY CARE DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021– APRIL 2025
  • TABLE 548 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
  • TABLE 549 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025
  • TABLE 550 MEDTRONIC: COMPANY OVERVIEW
  • TABLE 551 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025
  • TABLE 552 MEDTRONIC PLC: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025
  • TABLE 553 RESMED INC.: COMPANY OVERVIEW
  • TABLE 554 RESMED INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025
  • TABLE 555 RESMED INC: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 556 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW
  • TABLE 557 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025
  • TABLE 558 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW
  • TABLE 559 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025
  • TABLE 560 DRÄGERWERK AG & CO. KGAA: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 561 DRÄGERWERK AG & CO. KGAA: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025
  • TABLE 562 MASIMO: COMPANY OVERVIEW
  • TABLE 563 MASIMO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025
  • TABLE 564 MASIMO: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 565 MASIMO: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025
  • TABLE 566 GETINGE: COMPANY OVERVIEW
  • TABLE 567 GETINGE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025
  • TABLE 568 GETINGE: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 569 GETINGE: EXPANSIONS, JANUARY 2021–APRIL 2025
  • TABLE 570 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
  • TABLE 571 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025
  • TABLE 572 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 573 GE HEALTHCARE: COMPANY OVERVIEW
  • TABLE 574 GE HEALTHCARE: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 575 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025
  • TABLE 576 HILLROM & WELCH ALLYN (BAXTER): COMPANY OVERVIEW
  • TABLE 577 HILLROM & WELCH ALLYN (BAXTER): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MARCH 2024
  • TABLE 578 HILLROM & WELCH ALLYN (BAXTER): DEALS, JANUARY 2021–MARCH 2024
  • TABLE 579 ADAPTHEALTH, LLC: COMPANY OVERVIEW
  • TABLE 580 TELEFLEX INCORPORATED: COMPANY OVERVIEW
  • TABLE 581 AIR LIQUIDE: COMPANY OVERVIEW
  • TABLE 582 AIR LIQUIDE: DEALS, JANUARY 2021–APRIL 2025
  • TABLE 583 ICU MEDICAL, INC.: COMPANY OVERVIEW
  • TABLE 584 ICU MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025
  • TABLE 585 ICU MEDICAL, INC.: DEALS, JANUARY 2021–MARCH 2024
  • TABLE 586 HAMILTON MEDICAL: COMPANY OVERVIEW
  • TABLE 587 HAMILTON MEDICAL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MARCH 2024
LIST OF FIGURES
 
  • FIGURE 1 RESPIRATORY CARE DEVICES MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
  • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE), BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE), BY END USER, DESIGNATION, AND REGION
  • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: RESMED INC.
  • FIGURE 9 SUPPLY-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2024)
  • FIGURE 10 DEMAND-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2024)
  • FIGURE 11 TOTAL MARKET SIZE ESTIMATION: RESPIRATORY CARE DEVICES MARKET
  • FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030)
  • FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 14 TOP-DOWN APPROACH
  • FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 16 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)
  • FIGURE 17 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 18 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 19 GEOGRAPHIC SNAPSHOT: RESPIRATORY CARE DEVICES MARKET
  • FIGURE 20 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD
  • FIGURE 21 INDIA ACCOUNTED FOR LARGEST SHARE OF RESPIRATORY CARE DEVICES MARKET IN ASIA PACIFIC IN 2024
  • FIGURE 22 INDIA TO GROW AT HIGHEST RATE DURING FORECAST PERIOD
  • FIGURE 23 NORTH AMERICA WILL CONTINUE TO DOMINATE RESPIRATORY CARE DEVICES MARKET DURING FORECAST PERIOD
  • FIGURE 24 DEVELOPING MARKETS TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD
  • FIGURE 25 RESPIRATORY CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 26 GLOBAL GERIATRIC POPULATION, BY REGION
  • FIGURE 27 ANNUAL DATA OF DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE
  • FIGURE 28 IMPACT OF INNOVATIVE SOLUTIONS
  • FIGURE 29 INTRODUCTION OF INNOVATIVE SOLUTIONS FOR SLEEP APNEA TREATMENT
  • FIGURE 30 VALUE CHAIN ANALYSIS
  • FIGURE 31 SUPPLY CHAIN ANALYSIS
  • FIGURE 32 ADJACENT MARKETS FOR RESPIRATORY CARE DEVICES MARKET
  • FIGURE 33 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR RESPIRATORY CARE DEVICES MARKET
  • FIGURE 34 TOP PATENT APPLICANT COUNTRIES FOR RESPIRATORY CARE DEVICES (JANUARY 2014–DECEMBER 2024)
  • FIGURE 35 RESPIRATORY CARE DEVICES MARKET: ECOSYSTEM MARKET MAP
  • FIGURE 36 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN RESPIRATORY CARE DEVICES MARKET
  • FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY CARE DEVICES
  • FIGURE 38 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES
  • FIGURE 39 RESPIRATORY CARE DEVICES MARKET: REGIONAL GROWTH OPPORTUNITIES
  • FIGURE 40 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
  • FIGURE 41 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET SNAPSHOT
  • FIGURE 42 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN RESPIRATORY CARE DEVICES MARKET (2020−2024)
  • FIGURE 43 RESPIRATORY CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2024)
  • FIGURE 44 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 45 RESPIRATORY CARE DEVICES MARKET: COMPANY FOOTPRINT
  • FIGURE 46 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 47 EV/EBITDA OF KEY VENDORS
  • FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 49 RESPIRATORY CARE DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
  • FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024)
  • FIGURE 51 MEDTRONIC: COMPANY SNAPSHOT (2024)
  • FIGURE 52 RESMED INC.: COMPANY SNAPSHOT (2024)
  • FIGURE 53 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2024)
  • FIGURE 54 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2024)
  • FIGURE 55 MASIMO: COMPANY SNAPSHOT (2024)
  • FIGURE 56 GETINGE: COMPANY SNAPSHOT (2024)
  • FIGURE 57 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
  • FIGURE 58 GE HEALTHCARE: COMPANY SNAPSHOT (2024)
  • FIGURE 59 HILLROM & WELCH ALLYN (BAXTER): COMPANY SNAPSHOT (2024)
  • FIGURE 60 ADAPTHEALTH, LLC: COMPANY SNAPSHOT (2024)
  • FIGURE 61 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2024)
  • FIGURE 62 AIR LIQUIDE: COMPANY SNAPSHOT (2024)
  • FIGURE 63 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024)

 

This study involved four major activities in estimating the current respiratory care devices market size. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the respiratory care devices market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, as well as key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the respiratory care devices market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents for the respiratory care devices market is provided below:

Respiratory Care Devices Market

Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 3: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.

Source: MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global respiratory care devices market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global respiratory care devices market was split into various segments and subsegments based on:

  • List of major players operating in the products market at the regional and/or country level
  • Product mapping of various respiratory care device manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from respiratory care devices (or the nearest reported business unit/product category)
  • Revenue mapping of major players to covered
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Bottom-up Approach and Top-down Approach

Respiratory Care Devices Market

Data Triangulation

After arriving at the overall size of the global respiratory care devices market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Respiratory care is a healthcare specialty that provides diagnostic evaluation, management, control, therapy, and monitoring of cardiopulmonary system diseases and disorders. Respiratory care devices are extensively used in general & surgical wards and ICUs as a life support measure.

Stakeholders

  • Respiratory Care Device Manufacturers and Distributors
  • Healthcare Institutions (Hospitals, Laboratories, Medical Schools, and Outpatient Clinics)
  • Research Institutes
  • Contract Manufacturing Organizations (CMOs)
  • Government Associations
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors

Report Objectives

  • To define, describe, and forecast the respiratory care devices market based on product type, disease indication, end user, and region
  • To forecast the market size based on five key regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • To strategically analyze the industry trends, technology trends, pricing analysis, regulatory scenario, supply/value chain, ecosystem mapping, Porter’s Five Forces, patent analysis, key stakeholders and buying criteria, and conferences & events
  • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall respiratory care devices market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To strategically profile key players in the respiratory care devices market and comprehensively analyze their core competencies
  • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall respiratory care devices market
  • To benchmark players within the market using the proprietary “Competitive Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy
  • To analyze the generative AI impact on the respiratory care devices market

 

Previous Versions of this Report

Respiratory Care Devices Market by Product (Therapeutic (CPAP, Ventilator, Nebulizer, Inhaler), Pulse Oximeter, Spirometer), Indication, End User, Key stakeholders & Expectations, Unmet needs, Buying Criteria, Reimbursement - Global Forecast to 2028

Report Code MD 1583
Published in Sep, 2023, By MarketsandMarkets™

Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), COVID-19 Impact - Global Forecast to 2026

Report Code MD 1583
Published in Oct, 2021, By MarketsandMarkets™

Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End-User (Hospital, Home Care), Indication - Global Forecast to 2025

Report Code MD 1583
Published in Jun, 2020, By MarketsandMarkets™

Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), Indication - Global Forecast to 2024

Report Code MD 1583
Published in Jul, 2019, By MarketsandMarkets™

Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables), End User (Hospital, Home Care), Indication - Global Forecast to 2021

Report Code MD 1583
Published in Feb, 2017, By MarketsandMarkets™

Respiratory Care Devices Market by Product (Therapeutic (Ventilator, Mask, PAP Device, Inhaler, Nebulizer), Monitoring (Pulse Oximeter, Capnograph), Diagnostic, Consumables & Accessories), by End User (Hospital, Home Care) - Global Forecast to 2020

Report Code MD 1583
Published in Sep, 2015, By MarketsandMarkets™

Respiratory Care Devices Market – Therapeutic (Humidifiers, Nebulizers, PAP devices, Ventilators, Inhalers), Monitoring (Pulse Oximeter, Capnographs, disposables), Diagnostic – Spirometer, Polysomnograph) & Preterm care (Nasal CPAP, Oxygen hoods, ECMO, NO delivery units, ventilators) - Global Trends & Forecasts up till 2015

Report Code MD 1583
Published in Apr, 2011, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Respiratory Care Devices Market

DMCA.com Protection Status